 Immunohistochemistry
"Immunohistochemistry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
| Descriptor ID |
D007150
|
| MeSH Number(s) |
E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
|
| Concept/Terms |
Immunolabeling Techniques- Immunolabeling Techniques
- Immunolabeling Technique
- Technique, Immunolabeling
- Techniques, Immunolabeling
- Immunolabeling Technics
- Immunolabeling Technic
- Technic, Immunolabeling
- Technics, Immunolabeling
Immunogold Techniques- Immunogold Techniques
- Immunogold Technique
- Technique, Immunogold
- Techniques, Immunogold
- Immunogold Technics
- Immunogold Technic
- Technic, Immunogold
- Technics, Immunogold
Immunogold-Silver Techniques- Immunogold-Silver Techniques
- Immunogold Silver Techniques
- Immunogold-Silver Technique
- Technique, Immunogold-Silver
- Techniques, Immunogold-Silver
- Immunogold-Silver Technics
- Immunogold Silver Technics
- Immunogold-Silver Technic
- Technic, Immunogold-Silver
- Technics, Immunogold-Silver
|
Below are MeSH descriptors whose meaning is more general than "Immunohistochemistry".
Below are MeSH descriptors whose meaning is more specific than "Immunohistochemistry".
This graph shows the total number of publications written about "Immunohistochemistry" by people in this website by year, and whether "Immunohistochemistry" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 0 | 1 | 1 | | 1988 | 1 | 14 | 15 | | 1989 | 1 | 16 | 17 | | 1990 | 0 | 10 | 10 | | 1991 | 1 | 15 | 16 | | 1992 | 0 | 19 | 19 | | 1993 | 0 | 33 | 33 | | 1994 | 0 | 18 | 18 | | 1995 | 0 | 30 | 30 | | 1996 | 0 | 36 | 36 | | 1997 | 2 | 36 | 38 | | 1998 | 0 | 27 | 27 | | 1999 | 0 | 37 | 37 | | 2000 | 1 | 32 | 33 | | 2001 | 0 | 47 | 47 | | 2002 | 0 | 45 | 45 | | 2003 | 0 | 56 | 56 | | 2004 | 0 | 49 | 49 | | 2005 | 0 | 64 | 64 | | 2006 | 0 | 65 | 65 | | 2007 | 0 | 51 | 51 | | 2008 | 3 | 56 | 59 | | 2009 | 2 | 69 | 71 | | 2010 | 1 | 64 | 65 | | 2011 | 2 | 51 | 53 | | 2012 | 0 | 57 | 57 | | 2013 | 0 | 49 | 49 | | 2014 | 3 | 54 | 57 | | 2015 | 4 | 30 | 34 | | 2016 | 2 | 36 | 38 | | 2017 | 3 | 33 | 36 | | 2018 | 1 | 26 | 27 | | 2019 | 1 | 15 | 16 | | 2020 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunohistochemistry" by people in Profiles.
-
Gandhi JS, Smith SC, Paner GP, McKenney JK, Sekhri R, Osunkoya AO, Baras AS, DeMarzo AM, Cheville JC, Jimenez RE, Trpkov K, Colecchia M, Ro JY, Montironi R, Menon S, Hes O, Williamson SR, Hirsch MS, Netto GJ, Fine SW, Sirohi D, Kaushal S, Sangoi A, Robinson BD, Kweldam CF, Humphrey PA, Hansel DE, Schultz L, Magi-Galluzzi C, Przybycin CG, Shah RB, Mehra R, Kunju LP, Aron M, Kryvenko ON, Kench JG, Kuroda N, Tavora F, van der Kwast T, Grignon DJ, Epstein JI, Reuter VE, Amin MB. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020 05; 44(5):673-680.
-
Chow M, Kamath S, Choi D, Kim G, Ahronowitz I. Violaceous Plaques and Nodules: Challenge. Am J Dermatopathol. 2020 Jan; 42(1):e3.
-
McGregor SM, Furtado LV, Montag AG, Brooks R, Lastra RR. Epithelioid Trophoblastic Tumor: Expanding the Clinicopathologic Spectrum of a Rare Malignancy. Int J Gynecol Pathol. 2020 Jan; 39(1):8-18.
-
Chow M, Kamath S, Choi D, Kim G, Ahronowitz I. Violaceous Plaques and Nodules: Answer. Am J Dermatopathol. 2020 Jan; 42(1):63-64.
-
Cohen EEW, Pishvaian MJ, Shepard DR, Wang D, Weiss J, Johnson ML, Chung CH, Chen Y, Huang B, Davis CB, Toffalorio F, Thall A, Powell SF. A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. J Immunother Cancer. 2019 12 04; 7(1):342.
-
Miller GC, Kumarasinghe MP, Borowsky J, Choi WT, Setia N, Clauditz T, Gidwani R, Sufiyan W, Lauwers GY, Brown IS. Clinicopathological features of pyloric gland adenomas of the duodenum: a multicentre study of 57 cases. Histopathology. 2020 Feb; 76(3):404-410.
-
London NR, Rooper LM, Bishop JA, Xu H, Bernhardt LJ, Ishii M, Hann CL, Taube JM, Izumchenko E, Gaykalova DA, Gallia GL. Expression of Programmed Cell Death Ligand 1 and Associated Lymphocyte Infiltration in Olfactory Neuroblastoma. World Neurosurg. 2020 Mar; 135:e187-e193.
-
Zhang D, Gonzalez RS, Feely M, Umrau K, Lee H, Allende DS, Karamchandani DM, Zaleski M, Lin J, Westerhoff M, Zhang X, Alpert L, Liao X, Lai J, Liu X. Clinicopathologic features of Buschke-Löwenstein tumor: a multi-institutional analysis of 38 cases. Virchows Arch. 2020 Apr; 476(4):543-550.
-
Setia N, Ahn S, Han HS, Park DY, Lauwers GY. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma. Hum Pathol. 2019 12; 94:64-70.
-
Mei L, Alikhan M, Mujacic I, Parilla M, Antic T. Genomic Alterations in Undifferentiated Malignant Tumors with Rhabdoid Phenotype and Loss of BRG1 Immunoexpression Identified by Fine Needle Aspirates. Acta Cytol. 2019; 63(5):438-444.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|